Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-56.31%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-56.31%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
0.5
-7x
Never
—
-100.00%
20%
—
5 Years
Score0.5
Net Growth-7x
Net TrendNever
Net Income Consistency—
Rev Growth-100.00%
Rev Trend20%
Revenue Consistency—
Revolution Medicines Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 42M to $ 0.00 and net income went from -$ 108M to -$ 1.13B. Revenue increased in 1 of those 5 years; net income in 0.
Revolution Medicines Inc currently holds a 5-year HDB Score of 0.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 205.26 | — |
1 Year2025-08-12 | $ 35.26 | 482.13% |
5 Years2021-08-12 | $ 23.95 | 8x |
All Time2020-02-13 | $ 28.90 | 7x |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-02-13 |
|---|---|---|---|---|
| Price | $ 205.26 | $ 35.26 | $ 23.95 | $ 28.90 |
| Return | — | 482.13% | 8x | 7x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 1.76B | $ 3.93B |
| 2025 | $ 0.00 | -$ 1.13B | $ 2.02B |
| 2024 | $ 0.00 | -$ 600M | $ 2.28B |
| 2023 | $ 11M | -$ 436M | $ 1.85B |
| 2022 | $ 35M | -$ 248M | $ 644M |
| 2021 | $ 29M | -$ 187M | $ 577M |
| IPO2020 | $ 42M | -$ 108M | $ 440M |
Explore beyond RVMD
You're looking at Revolution Medicines Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
